Although several TNF ligands were identified as elevated in both tumor epithelial and stroma in our analysis, our data showed that pre-treatment with specific anti-TNFR1 antibody almost completely blocked the effect of synthetic CTGF in the CTGF-low control-HMLER and shCTGFs cells. Here, CCN2 is linked to neoplasm.